Download FREE Report Sample
Download Free sampleMoxifloxacin hydrochloride (moxifloxacin HCl) is used to treat a variety of bacterial infections. Moxifloxacin HCl is a broad-spectrum fourth generation fluoroquinolone antibiotic. These antibiotics prevent unwinding of double-stranded DNA by binding DNA gyrase or DNA topoisomerase. By preventing the formation of single-stranded DNA, inhibit bacterial replication.
Moxifloxacin HCl Market contains market size and forecasts of Moxifloxacin HCl in global, including the following market information:
Global Moxifloxacin HCl Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Moxifloxacin HCl Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Moxifloxacin HCl companies in 2021 (%)
The global Moxifloxacin HCl market was valued at 121.4 million in 2021 and is projected to reach US$ 115.1 million by 2028, at a CAGR of -0.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
98.0%-99.5% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Moxifloxacin HCl include Bayer, Rivopharm, Actavis UK, MERCK, Cayman, Allergan, Tecoland, BOC Sciences and Aurobindo and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Moxifloxacin HCl manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Moxifloxacin HCl Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Moxifloxacin HCl Market Segment Percentages, by Type, 2021 (%)
98.0%-99.5%
99.5-99.9%
More than or equal to 99.9%
Global Moxifloxacin HCl Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Moxifloxacin HCl Market Segment Percentages, by Application, 2021 (%)
Oral Tablets
Injection
Ophthalmic Drugs
Global Moxifloxacin HCl Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Moxifloxacin HCl Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Moxifloxacin HCl revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Moxifloxacin HCl revenues share in global market, 2021 (%)
Key companies Moxifloxacin HCl sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Moxifloxacin HCl sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Rivopharm
Actavis UK
MERCK
Cayman
Allergan
Tecoland
BOC Sciences
Aurobindo
NIVIKA Chemo Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy